By Michele Maatouk
Date: Monday 17 Aug 2020
(Sharecast News) - French pharmaceutical group Sanofi has agreed to buy US rival Principia Biopharma for $3.68bn, further strengthening its core research and development areas of autoimmune and allergic diseases.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 0.00 |
| Closing Price Change | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $0.00 |
| 52 Week Low | $0.00 |
| Volume | 0 |
| Shares Issued | 23.87m |
| RiskGrade | 145 |
You are here: research